Podcast
Questions and Answers
What is an indicator of poor differentiation in a colorectal carcinoma histological section?
What is an indicator of poor differentiation in a colorectal carcinoma histological section?
Which of the following is a tumor marker that can be monitored in colorectal cancers?
Which of the following is a tumor marker that can be monitored in colorectal cancers?
What symptom might commonly indicate advanced prostatic carcinoma?
What symptom might commonly indicate advanced prostatic carcinoma?
In assessing a prostate biopsy, what histological characteristic would indicate malignancy?
In assessing a prostate biopsy, what histological characteristic would indicate malignancy?
Signup and view all the answers
What is the significance of an elevated serum Prostate Specific Antigen (PSA) level?
What is the significance of an elevated serum Prostate Specific Antigen (PSA) level?
Signup and view all the answers
What is the highest grade in the Gleason Scale for prostate cancer?
What is the highest grade in the Gleason Scale for prostate cancer?
Signup and view all the answers
What type of cancer is least sensitive to radiotherapy?
What type of cancer is least sensitive to radiotherapy?
Signup and view all the answers
Which chemotherapy drug acts on cells in mitosis and the G1 and S phases?
Which chemotherapy drug acts on cells in mitosis and the G1 and S phases?
Signup and view all the answers
Which factor is NOT considered when determining radiotherapy treatment?
Which factor is NOT considered when determining radiotherapy treatment?
Signup and view all the answers
What is a key marker for the diagnosis and treatment prediction in hormone therapy?
What is a key marker for the diagnosis and treatment prediction in hormone therapy?
Signup and view all the answers
Which tumor marker is specifically associated with hepatocellular carcinoma?
Which tumor marker is specifically associated with hepatocellular carcinoma?
Signup and view all the answers
What is NOT an aim of cancer screening?
What is NOT an aim of cancer screening?
Signup and view all the answers
Which type of cancer is characterized by fairly high sensitivity to radiotherapy?
Which type of cancer is characterized by fairly high sensitivity to radiotherapy?
Signup and view all the answers
What does the 'T' in the TNM staging system represent?
What does the 'T' in the TNM staging system represent?
Signup and view all the answers
Which of the following corresponds to Stage II Hodgkin’s disease?
Which of the following corresponds to Stage II Hodgkin’s disease?
Signup and view all the answers
What is the significance of tumor grade?
What is the significance of tumor grade?
Signup and view all the answers
Which cancer treatment is classified as a newer agent?
Which cancer treatment is classified as a newer agent?
Signup and view all the answers
What does a well-differentiated tumor indicate?
What does a well-differentiated tumor indicate?
Signup and view all the answers
What type of information does the 'N' in the TNM system provide?
What type of information does the 'N' in the TNM system provide?
Signup and view all the answers
Which tumor marker is associated with monitoring testicular cancer?
Which tumor marker is associated with monitoring testicular cancer?
Signup and view all the answers
What factor does NOT influence the grading of breast cancer?
What factor does NOT influence the grading of breast cancer?
Signup and view all the answers
What is the purpose of cervical screening?
What is the purpose of cervical screening?
Signup and view all the answers
What is a crucial factor for breast cancer screening?
What is a crucial factor for breast cancer screening?
Signup and view all the answers
Which type of tumor is most likely found in an 18-year-old male with a testicular swelling?
Which type of tumor is most likely found in an 18-year-old male with a testicular swelling?
Signup and view all the answers
What is a common characteristic feature found in histology of Hodgkin's disease?
What is a common characteristic feature found in histology of Hodgkin's disease?
Signup and view all the answers
Which factor is NOT relevant in improving prognosis in cancer patients?
Which factor is NOT relevant in improving prognosis in cancer patients?
Signup and view all the answers
What is the primary method used in breast cancer screening?
What is the primary method used in breast cancer screening?
Signup and view all the answers
What is a next step after surgery for a patient with testicular tumors?
What is a next step after surgery for a patient with testicular tumors?
Signup and view all the answers
What can affect the staging of a breast cancer patient?
What can affect the staging of a breast cancer patient?
Signup and view all the answers
Study Notes
Session 12: Neoplasia IV - Incidence, Prognosis & Treatment
- The session covered neoplasia IV, focusing on incidence, prognosis, and treatment.
- Objectives included understanding malignant tumor staging (rectum, breast, prostate, bladder, Hodgkin's disease), malignant tumor grading (squamous cell carcinoma, breast cancer, colon cancer), and the biological basis for cancer treatments (radiotherapy, chemotherapy, hormone therapy, newer agents like Herceptin).
- Tumor markers (carcinoembryonic antigen, human chorionic gonadotropin, alpha fetoprotein) and screening (cervix, breast) were also discussed.
- Cancer incidence and mortality data (2008 estimates) by site and sex were presented.
- The presentation of the commonest ten cancers by primary site (2009) was shown graphically.
- The incidence rate of commonest ten cancer deaths by site (2009) in Iraq was displayed in a separate graph showing data per 100,000 population.
- Tumor behavior prediction relies on staging (TNM) and grading.
Staging (TNM)
- Staging (TNM) evaluates tumor size, lymph node status (N), and metastasis (M).
- It is based on objective pathology and clinical criteria.
- TNM is a crucial prognostic tool.
- T classifications (tumor sizes): T1 (less than 2 cm), T2 (2-5 cm), T3 (involvement of skin or chest wall).
- N classifications (lymph node status): N0 (no involvement), N1 (mobile nodes involved).
- M classifications (metastasis): M0 (no metastasis), M1 (demonstrable metastasis).
- Specific staging systems exist for different cancers, such as Dukes staging for rectal neoplasms, and Ann Arbor staging for Hodgkin's disease.
- Ann Arbor staging categorizes Hodgkin's disease based on the involved lymph node groups (I to IV) and presence of B symptoms (fever, sweats, weight loss) in addition to the location of nodes involved.
Grading
- Grading assesses tumor differentiation.
- Well-differentiated tumors closely resemble the original cell type, while poorly differentiated tumors show significant structural differences.
- Immunohistochemical stains are used to confirm differentiation.
- Specific grading systems exist for different cancers (e.g., Glasgow system for breast cancer, Gleason scoring for prostate cancer).
- Grading provides information about the tumor's aggressiveness and potential response to treatment. Grading factors include tubule formation, nuclear variation, and number of mitoses. Examples include well differentiated adenocarcinoma and moderately differentiated adenocarcinoma for breast cancer and Gleason scale for prostate cancer.
Treatment and Response Prediction
- Primary treatment depends on the tumor type and stage.
- Adjuvant treatment is given after primary treatment to reduce the risk of recurrence or metastasis.
- Radiotherapy factors include radiation type, cumulative dose, rate of delivery, and target tissue susceptibility.
- Chemotherapy targets specific stages of the cell cycle impacting rapidly-dividing cells such as bone marrow. Examples of chemotherapy drugs include Cyclophosphamide, Vincristine and Methotrexate acting on different cell division phases.
- Hormone therapy is commonly used for cancers sensitive to hormones (e.g., breast, prostate).
- Response prediction involves detecting hormone receptors (estrogen receptor) and other markers (like HER-2 amplification/overexpression) for effective treatment strategies.
Tumor Markers
- Tumor markers are substances released from tumors into the bloodstream.
- These substances aid in diagnosing cancer and assessing treatment response.
- Examples of tumor markers include alpha-fetoprotein, human chorionic gonadotropin, acid phosphatase, and prostate-specific antigen.
- Tumor markers may aid in establishing diagnosis and monitoring treatment outcomes, hence helping in follow ups.
Screening
- Screening aims to detect pre-malignant, non-invasive, and early-invasive cancers to improve prognosis and survival.
- Common screening targets are cervix, breast, large intestine, and prostate.
- Specific screening methods (e.g., Pap smear for cervix, mammography for breast) and factors including age, population at risk, cytological examination are critical.
Small Group Questions
- Various cases and accompanying questions (e.g., case scenarios of testicular teratoma, Hodgkin's disease, breast carcinoma, and colorectal carcinoma) were presented along with relevant graphics, histology and additional information to assist decision making.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
Test your knowledge on various tumor markers and histological characteristics in different types of cancers, specifically focusing on colorectal and prostate cancers. This quiz covers cancer diagnosis, treatment predictions, and the significance of specific markers in oncology.